Relapsed/Refractory Acute Myeloid Leukemia Clinical Trials

39 clinical trials for Relapsed/Refractory Acute Myeloid Leukemia across international registries, including 12 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Evaluate the Safety, Tolerability, Pharmacokinetic Profile, Efficacy of Bl-M11D1 — RECRUITING · PHASE1
• Individualized AML Treatment — RECRUITING
• CD70-CAR-NK Cell Therapy for T Cell Lymphoma and Acute Myeloid Leukemia — RECRUITING · PHASE1
• Clinical Study of Venetoclax Combined With CACAG Regimen in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia — RECRUITING · PHASE2
• Long-Term Follow-up Study — RECRUITING
• CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) — RECRUITING · PHASE1
• Study of NMS-03597812 in Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia — RECRUITING · PHASE1
• A Study of BL-M11D1 in Patients With Relapsed/Refractory Acute Myeloid Leukemia — RECRUITING · PHASE1
• Clinical Study of Anti-FLT3 CAR-T Cells for the Treatment of Relapsed/Refractory AML — RECRUITING · PHASE1
• Thiotepa Combined With Busulfan and Fludarabine Conditioning Regimen for Haploidentical Hematopoietic Stem Cell Transplantation in Elderly Patients With High-Risk Acute Myeloid Leukemia — RECRUITING · PHASE2
• Safety and Efficacy of NK520 to Treat Relapsed/Refractory Acute Myeloid Leukemia — RECRUITING · PHASE1
• A Phase 1 Clinical Trail of NTQ2494 Tablets in Patients With Advanced Hematological Malignancies — RECRUITING · PHASE1
• ENLIGHT-AML - An Open-label, Study of GB3226 in Patients With Relapsed/Refractory Acute Myeloid Leukemia — WITHDRAWN · PHASE1
• A Clinical Study to Investigate the Safety and Efficacy of Off-the-Shelf iNKT Cell Injection Targeting CD33/CD70 in Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia — NOT_YET_RECRUITING · PHASE1
• Salvage Haploidentical HSCT With DLI and Targeted Therapy for R/R AML — NOT_YET_RECRUITING
• A Clinical Study to Explore the Safety and Efficacy of CT1390B in Relapsed/ Refractory Acute Myeloid Leukemia — NOT_YET_RECRUITING · PHASE1
• A Clinical Study to Explore the Safety and Efficacy of CT0991 in Relapsed/Refractory Acute Myeloid Leukemia — SUSPENDED · PHASE1
• A Clinical Study to Explore the Safety and Efficacy of CT0991 in Relapsed/ Refractory Acute Myeloid Leukemia — NOT_YET_RECRUITING · PHASE1
• Study Evaluating Safety and Efficacy of UCART123v1.2 in Patients With Relapsed/Refractory Acute Myeloid Leukemia — ACTIVE_NOT_RECRUITING · PHASE1
• Genetic Ablation of CD33 in HSC to Broaden the Therapeutic Index of CD33-directed Immunotherapy in Patients with AML — NOT_YET_RECRUITING · PHASE1
• A PHASE I/II STUDY TO EVALUATE THE SAFETY AND EFFICACY OF MEBENDAZOLE IN COMBINATION WITH LOW-DOSE ARA-C IN ELDERLY PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA (MAIL) — OTHER · PHASE2
• Clinical Study on the Safety and Efficacy of Autologous CD84 Chimeric Antigen Receptor T-Cell Therapy for Adult Relapsed/Refractory Acute Myeloid Leukemia. — NOT_YET_RECRUITING · PHASE1
• Safety, Tolerability, PK, PD, and Efficacy of AMG 427 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia — TERMINATED · PHASE1
• An adaptive open-label multicentre phase 1/2 trial, to determine the recommended phase 2 dose of CCTx-001, and to assess safety, tolerability, and clinical activity in patients with relapsed/refractory acute myeloid leukaemia (RESOLVE AML 001) — NOT_YET_RECRUITING · PHASE2
• Safety and Efficacy of NK520 to Treat Pediatric Relapsed/Refractory Acute Myeloid Leukemia — OTHER · PHASE1
• Phase IIa Study to Assess Safety and Efficacy in the Relapsed/Refractory Acute Myeloid Leukemia — OTHER · PHASE2
• Arsenic Trioxide With Cyclophosphamide in Patients With Relapsed/Refractory Acute Myeloid Leukemia — TERMINATED · PHASE1
• US Expanded Access Program for Magrolimab in Patients With Relapsed or Refractory Acute Myeloid Leukemia — TERMINATED
• Pilot Study of Crenolanib Combined With Standard Salvage Chemotherapy in Subjects With R/R AML — COMPLETED · PHASE1
• Study Evaluating the Safety, Tolerability, and Efficacy of FLT3 CAR-T AMG 553 in FLT3-positive Relapsed/Refractory AML — WITHDRAWN · PHASE1
• A Study of PRT543 in Participants With Advanced Solid Tumors and Hematologic Malignancies — COMPLETED · PHASE1
• UTAA06 Injection in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia — OTHER · PHASE1
• Clinical Study of UTAA06 Injection in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia — OTHER · PHASE1
• Efficacy/Safety of CPI-613 in Combination With HD Cyt. and Mito. vs HD Cyt. and Mito. in Older Patients With R/R AML — TERMINATED · PHASE3
• LILRB4 STAR-T Cells in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia — COMPLETED · PHASE1
• A Randomized Trial of a Combination of Nintedanib/Placebo in Combination With Induction Chemotherapy for Patients With Refractory or First Relapse Acute Myeloid Leukemia — COMPLETED · PHASE2
• A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of Max-40279-01 in Combination With Azacitidine (AZA) in Patients With Myelodysplastic Syndrome (MDS) or Relapsed/Refractory Acute Myeloid Leukemia (R/R AML) — OTHER · PHASE1
• CAR-T Cells Therapy in Relapsed/Refractory Acute Myeloid Leukemia — TERMINATED · NA
• Decitabine for Myelodysplastic Syndromes and Acute Myeloid Leukemia Before Allogeneic Hematopoietic Cell Transplantation — OTHER · PHASE4

Refine this search